Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
Authors
Keywords
Neutrophil to lymphocyte ratio, Prognostic factor, Tumor-related inflammation, Non-small cell lung cancer
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 62, Issue 3, Pages 471-479
Publisher
Springer Nature
Online
2012-09-17
DOI
10.1007/s00262-012-1347-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy
- (2012) Manabu Kaneko et al. ONCOLOGY
- Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer
- (2012) Hiroshi Sato et al. WORLD JOURNAL OF SURGERY
- Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
- (2011) Basem Azab et al. ANNALS OF SURGICAL ONCOLOGY
- Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer
- (2011) Reem Z. Sharaiha et al. ANNALS OF SURGICAL ONCOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Prognostic Immune Markers in Non–Small Cell Lung Cancer
- (2011) Kei Suzuki et al. CLINICAL CANCER RESEARCH
- The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
- (2010) Xin An et al. BIOMARKERS
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection
- (2010) Farhan Rashid et al. World Journal of Surgical Oncology
- Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy
- (2009) Andrea Koch et al. Journal of Thoracic Oncology
- Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
- (2008) HanByoul Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer
- (2008) Khaled M. Sarraf et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now